Stierner U - Search Results

1

Role functioning before start of adjuvant treatment was an independent prognostic factor for survival and time to failure. A report from the Nordic adjuvant interferon trial for patients with high-risk melanoma.

Brandberg Y, Johansson H, Aamdal S, Bastholt L, Hernberg M, Stierner U, von der Maase H, Hansson J; Nordic Melanoma Cooperative Group. Brandberg Y, et al. Among authors: stierner u. Acta Oncol. 2013 Aug;52(6):1086-93. doi: 10.3109/0284186X.2013.789140. Epub 2013 Apr 28. Acta Oncol. 2013. PMID: 23621752 Clinical Trial.

2

Dacarbazine-vindesine versus dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A randomised phase III trial.

Jungnelius U, Ringborg U, Aamdal S, Mattsson J, Stierner U, Ingvar C, Malmström P, Andersson R, Karlsson M, Willman K, Wist E, Bjelkengren G, Westberg R. Jungnelius U, et al. Among authors: stierner u. Eur J Cancer. 1998 Aug;34(9):1368-74. doi: 10.1016/s0959-8049(98)00068-9. Eur J Cancer. 1998. PMID: 9849419 Clinical Trial.

3

CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas.

Hashemi J, Platz A, Ueno T, Stierner U, Ringborg U, Hansson J. Hashemi J, et al. Among authors: stierner u. Cancer Res. 2000 Dec 15;60(24):6864-7. Cancer Res. 2000. PMID: 11156381

4

Haplotype analysis and age estimation of the 113insR CDKN2A founder mutation in Swedish melanoma families.

Hashemi J, Bendahl PO, Sandberg T, Platz A, Linder S, Stierner U, Olsson H, Ingvar C, Hansson J, Borg A. Hashemi J, et al. Among authors: stierner u. Genes Chromosomes Cancer. 2001 Jun;31(2):107-16. doi: 10.1002/gcc.1124. Genes Chromosomes Cancer. 2001. PMID: 11319798

5

O6-methylguanine-DNA-methyltransferase expression and gene polymorphisms in relation to chemotherapeutic response in metastatic melanoma.

Ma S, Egyházi S, Ueno T, Lindholm C, Kreklau EL, Stierner U, Ringborg U, Hansson J. Ma S, et al. Among authors: stierner u. Br J Cancer. 2003 Oct 20;89(8):1517-23. doi: 10.1038/sj.bjc.6601270. Br J Cancer. 2003. PMID: 14562026 Free PMC article.

6

Invasive cutaneous malignant melanoma in Sweden, 1990-1999. A prospective, population-based study of survival and prognostic factors.

Lindholm C, Andersson R, Dufmats M, Hansson J, Ingvar C, Möller T, Sjödin H, Stierner U, Wagenius G; Swedish Melanoma Study Group. Lindholm C, et al. Among authors: stierner u. Cancer. 2004 Nov 1;101(9):2067-78. doi: 10.1002/cncr.20602. Cancer. 2004. PMID: 15372475 Free article.

7

The prognostic role of blood lymphocyte subset distribution in patients with resected high-risk primary or regionally metastatic melanoma.

Hernberg M, Mattila PS, Rissanen M, Hansson J, Aamdal S, Bastholt L, von der Maase H, Schmidt H, Stierner U, Tarkkanen J. Hernberg M, et al. Among authors: stierner u. J Immunother. 2007 Oct;30(7):773-9. doi: 10.1097/CJI.0b013e31814e0898. J Immunother. 2007. PMID: 17893569

8

Autoimmune antibodies and recurrence-free interval in melanoma patients treated with adjuvant interferon.

Bouwhuis MG, Suciu S, Collette S, Aamdal S, Kruit WH, Bastholt L, Stierner U, Salès F, Patel P, Punt CJ, Hernberg M, Spatz A, ten Hagen TL, Hansson J, Eggermont AM; EORTC Melanoma Group and the Nordic Melanoma Group. Bouwhuis MG, et al. Among authors: stierner u. J Natl Cancer Inst. 2009 Jun 16;101(12):869-77. doi: 10.1093/jnci/djp132. Epub 2009 Jun 9. J Natl Cancer Inst. 2009. PMID: 19509353

9

Two different durations of adjuvant therapy with intermediate-dose interferon alfa-2b in patients with high-risk melanoma (Nordic IFN trial): a randomised phase 3 trial.

Hansson J, Aamdal S, Bastholt L, Brandberg Y, Hernberg M, Nilsson B, Stierner U, von der Maase H; Nordic Melanoma Cooperative Group. Hansson J, et al. Among authors: stierner u. Lancet Oncol. 2011 Feb;12(2):144-52. doi: 10.1016/S1470-2045(10)70288-6. Epub 2011 Jan 20. Lancet Oncol. 2011. PMID: 21256809 Clinical Trial.

10

Testicular-cancer survivors experience compromised language following chemotherapy: findings in a Swedish population-based study 3-26 years after treatment.

Skoogh J, Steineck G, Stierner U, Cavallin-Ståhl E, Wilderäng U, Wallin A, Gatz M, Johansson B; Swenoteca. Skoogh J, et al. Among authors: stierner u. Acta Oncol. 2012 Feb;51(2):185-97. doi: 10.3109/0284186X.2011.602113. Epub 2011 Aug 18. Acta Oncol. 2012. PMID: 21851186

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

69 results

Search Page